Skip to main content

Phathom Pharmaceuticals, Inc.

PHAT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001783183

No open-market purchases or sales by Phathom Pharmaceuticals, Inc. insiders were filed in the last 90 days; 161 institutions reported holding it in 13F filings for Q2 2026, worth $782.1M in total; no superinvestor holds it.

13F holders, Q4 2021

Institutional positions in Phathom Pharmaceuticals, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
83
0 vs. Q3 2021
Shares held
28.6M
+3.03M (+11.9%) vs. Q3 2021
Total value
$562.0M
−$257.9M (−31.5%) vs. Q3 2021
New holders
18
33 more added
Sold out
18
14 more reduced

1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting PHAT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2021: 83 institutions
Q1 2021: 84 institutionsQ2 2021: 79 institutionsQ3 2021: 84 institutionsQ4 2021: 83 institutionsQ1 2022: 82 institutionsQ2 2022: 94 institutionsQ3 2022: 94 institutionsQ4 2022: 87 institutionsQ1 2023: 84 institutionsQ2 2023: 103 institutionsQ3 2023: 110 institutionsQ4 2023: 117 institutionsQ1 2024: 114 institutionsQ2 2024: 114 institutionsQ3 2024: 133 institutionsQ4 2024: 144 institutionsQ1 2025: 137 institutionsQ2 2025: 117 institutionsQ3 2025: 133 institutionsQ4 2025: 173 institutionsQ1 2026: 174 institutionsQ2 2026: 161 institutions
Value heldQ4 2021: $562.0M
Q1 2021: $919.2MQ2 2021: $843.6MQ3 2021: $819.8MQ4 2021: $562.0MQ1 2022: $349.1MQ2 2022: $230.0MQ3 2022: $334.3MQ4 2022: $316.6MQ1 2023: $219.7MQ2 2023: $612.6MQ3 2023: $452.7MQ4 2023: $503.3MQ1 2024: $588.2MQ2 2024: $598.6MQ3 2024: $1.31BQ4 2024: $541.2MQ1 2025: $401.4MQ2 2025: $550.5MQ3 2025: $733.6MQ4 2025: $1.03BQ1 2026: $765.5MQ2 2026: $782.1M
Institutions holding PHAT and their total value by quarter
QuarterHoldersValue
Q2 2026161$782.1M
Q1 2026174$765.5M
Q4 2025173$1.03B
Q3 2025133$733.6M
Q2 2025117$550.5M
Q1 2025137$401.4M
Q4 2024144$541.2M
Q3 2024133$1.31B
Q2 2024114$598.6M
Q1 2024114$588.2M
Q4 2023117$503.3M
Q3 2023110$452.7M
Q2 2023103$612.6M
Q1 202384$219.7M
Q4 202287$316.6M
Q3 202294$334.3M
Q2 202294$230.0M
Q1 202282$349.1M
Q4 202183$562.0M
Q3 202184$819.8M
Q2 202179$843.6M
Q1 202184$919.2M

Institutions, Q4 2021

Shares, value and share of portfolio for each institution holding Phathom Pharmaceuticals, Inc.; share changes are against Q3 2021.

Institutions holding PHAT in Q4 2021
InstitutionSharesValue% of portfolioChange in sharesAction
O'Shaughnessy Asset Management, LLC0$00.00%−14−100.0%Sold out
Berman Capital Advisors, LLC––––Not filed